Sound waves take on pancreatic cancer: new device trial shows promise

NCT ID NCT05601323

First seen Mar 21, 2026 · Last updated May 16, 2026 · Updated 3 times

Summary

This study tests whether adding a new high-intensity focused ultrasound device (Suizenji) to standard chemotherapy can help people with advanced pancreatic cancer that hasn't responded to first-line treatment. About 90 adults whose tumors can be seen on ultrasound will be randomly assigned to get chemo alone or chemo plus the ultrasound treatment. The main goal is to see if the combination helps people live longer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UNRESECTABLE PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aichi Medical University Hospital

    Nagakute-shi, Aichi, 480-1195, Japan

  • Kanagawa Cancer Center

    Yokohama-shi, Kanagawa, 241-8515, Japan

  • Tohoku University Hospital

    Sendai-shi, Miyagi, 980-8574, Japan

  • Tokyo Medical University Hospita

    Shinjuku-ku, Tokyo, 160-0023, Japan

  • Toyama University Hospital

    Toyama-shi, Toyama, 930-0194, Japan

  • Wakayama Medical University Hospital

    Wakayama-shi, Wakayama, 641-8510, Japan

  • Yokohama City University Medical Center

    Yokohama-shi, Kanagawa, 232-0024, Japan

Conditions

Explore the condition pages connected to this study.